Bhatt Elizabeth

SEC source: 0001193125-26-349810 · ownership.xml · derivative · entry 5

Bhatt Elizabeth · CIK 0001748622 · President and COO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 82,332

Underlying: Common Stock · 6,319 shares

Expires 2033-11-11

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_date: 1/48th of the shares subject to such option vest and become exercisable in substantially equal monthly installments on each monthly anniversary of August 1, 2023, subject to the Reporting Person's continuous service to the Issuer on each such date.

SEC source: 0001193125-26-349810 · ownership.xml · derivative · entry 4

Bhatt Elizabeth · CIK 0001748622 · President and COO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 62,230

Underlying: Common Stock · 18,681 shares

Expires 2034-09-22

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_date: 1/48th of the shares subject to such option vest and become exercisable in substantially equal monthly installments on each monthly anniversary of October 28, 2024, subject to the Reporting Person's continuous service to the Issuer on each such date.

SEC source: 0001193125-26-349810 · ownership.xml · nonDerivative · entry 3

Bhatt Elizabeth · CIK 0001748622 · President and COO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 174,209

F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 sales plan adopted by the Reporting Person on October 20, 2025.

SEC source: 0001193125-26-349810 · ownership.xml · nonDerivative · entry 2

Bhatt Elizabeth · CIK 0001748622 · President and COO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 199,209

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001193125-26-349810 · ownership.xml · nonDerivative · entry 1

Bhatt Elizabeth · CIK 0001748622 · President and COO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 192,890

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001193125-26-308073 · ownership.xml · derivative · entry 3

Bhatt Elizabeth · CIK 0001748622 · President and COO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 80,911

Underlying: Common Stock · 4,000 shares

Expires 2034-09-22

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_date: 1/48th of the shares subject to such option vest and become exercisable in substantially equal monthly installments on each monthly anniversary of October 28, 2024, subject to the Reporting Person's continuous service to the Issuer on each such date.

SEC source: 0001193125-26-308073 · ownership.xml · nonDerivative · entry 2

Bhatt Elizabeth · CIK 0001748622 · President and COO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 174,209

F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 sales plan adopted by the Reporting Person on October 20, 2025.

F2 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $33.49 to $34.24. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.

SEC source: 0001193125-26-308073 · ownership.xml · nonDerivative · entry 1

Bhatt Elizabeth · CIK 0001748622 · President and COO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 178,209

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001193125-26-161987 · ownership.xml · derivative · entry 5

Bhatt Elizabeth · CIK 0001748622 · President and COO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 84,911

Underlying: Common Stock · 4,000 shares

Expires 2034-09-22

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F5 · derivative.exercise_date: 1/48th of the shares subject to such option vest and become exercisable in substantially equal monthly installments on each monthly anniversary of October 28, 2024, contingent upon the consummation of the Issuer's initial public offering, and subject to the Reporting Person's continuous service to the Issuer on each such date.

SEC source: 0001193125-26-161987 · ownership.xml · nonDerivative · entry 4

Bhatt Elizabeth · CIK 0001748622 · President and COO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 174,209

F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 sales plan adopted by the Reporting Person on October 20, 2025.

F4 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $25.81 to $25.91. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.

SEC source: 0001193125-26-161987 · ownership.xml · nonDerivative · entry 3

Bhatt Elizabeth · CIK 0001748622 · President and COO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 174,535

F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 sales plan adopted by the Reporting Person on October 20, 2025.

F3 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $24.79 to $25.75. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.

SEC source: 0001193125-26-161987 · ownership.xml · nonDerivative · entry 2

Bhatt Elizabeth · CIK 0001748622 · President and COO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 175,636

F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 sales plan adopted by the Reporting Person on October 20, 2025.

F2 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $23.33 to $24.22. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.

SEC source: 0001193125-26-161987 · ownership.xml · nonDerivative · entry 1

Bhatt Elizabeth · CIK 0001748622 · President and COO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 178,209

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001193125-26-061675 · ownership.xml · derivative · entry 4

Bhatt Elizabeth · CIK 0001748622 · President and COO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 88,911

Underlying: Common Stock · 92,911 shares

Expires 2034-09-22

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · derivative.exercise_date: 1/48th of the shares subject to such option vest and become exercisable in substantially equal monthly installments on each monthly anniversary of October 28, 2024, contingent upon the consummation of the Issuer's initial public offering, and subject to the Reporting Person's continuous service to the Issuer on each such date.

SEC source: 0001193125-26-061675 · ownership.xml · nonDerivative · entry 3

Bhatt Elizabeth · CIK 0001748622 · President and COO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 174,209

F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 sales plan adopted by the Reporting Person on October 20, 2025.

F3 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $29.12 to $29.98. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.

SEC source: 0001193125-26-061675 · ownership.xml · nonDerivative · entry 2

Bhatt Elizabeth · CIK 0001748622 · President and COO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 176,009

F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 sales plan adopted by the Reporting Person on October 20, 2025.

F2 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $28.09 to $29.07. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.

SEC source: 0001193125-26-061675 · ownership.xml · nonDerivative · entry 1

Bhatt Elizabeth · CIK 0001748622 · President and COO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 178,209

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001193125-26-045097 · ownership.xml · derivative · entry 1

Bhatt Elizabeth · CIK 0001748622 · President and COO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 155,000

Underlying: Common Stock · 155,000 shares

Expires 2036-02-05

F1 · derivative.exercise_date: 2/48th of the shares subject to such option shall vest and become exercisable on March 1, 2026 and the remaining shares subject to the option shall vest in 46 substantially equal monthly installments on each monthly anniversary thereafter, subject to the Reporting Person's continuous service to the Issuer on each such date.

SEC source: 0000950170-25-106798 · ownership.xml · derivative · entry 1

Bhatt Elizabeth · CIK 0001748622 · President and COO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 95,000

Underlying: Common Stock · 95,000 shares

Expires 2035-08-06

F1 · derivative.exercise_date: 1/48th of the shares subject to such option shall vest and become exercisable in substantially equal monthly installments on each monthly anniversary of August 1, 2025, subject to the Reporting Person's continuous service to the Issuer on each such date.

SEC source: 0000950170-24-073195 · ownership.xml · derivative · entry 1

Bhatt Elizabeth · CIK 0001748622 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 800

Underlying: Common Stock · 800 shares

Expires 2034-06-12

F1 · derivative.exercise_date: The option was granted pursuant to the Issuer's Non-Employee Director Compensation Program. The option shall vest in full on the earlier to occur of (A) the first anniversary of the date of grant or (B) the next occurring annual meeting of the Issuer's stockholders, subject to the Reporting Person's continuous service on the board of directors of the Issuer through such vesting date.

SEC source: 0001209191-24-003705 · doc4.xml · derivative · entry 1

Bhatt Elizabeth · CIK 0001748622 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,000

Underlying: Common Stock · 2,000 shares

Expires 2034-02-18

F1 · derivative.exercise_date: The shares subject to the option will vest in substantially equal monthly installments over 12 months, commencing on February 19, 2024, subject to the Reporting Person's continued service with the Issuer through each vesting date.

SEC source: 0001209191-23-039191 · doc4.xml · derivative · entry 1

Bhatt Elizabeth · CIK 0001748622 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 20,000

Underlying: Common Stock · 20,000 shares

Expires 2033-06-21

F1 · derivative.exercise_date: The option was granted pursuant to the Issuer's Non-Employee Director Compensation Program. The option shall vest in full on the earlier to occur of (A) the first anniversary of the date of grant or (B) the next occurring annual meeting of the Issuer's stockholders, subject to the Reporting Person's continuous service on the board of directors of the Issuer through such vesting date.

SEC source: 0001209191-23-004576 · doc4.xml · derivative · entry 1

Bhatt Elizabeth · CIK 0001748622 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 30,000

Underlying: Common Stock · 30,000 shares

Expires 2033-01-19

F1 · derivative.exercise_date: The shares subject to the option will vest in substantially equal monthly installments over 12 months, commencing on January 20, 2023, subject to the Reporting Person's continued service with the Issuer through each vesting date.

SEC source: 0001209191-22-036441 · doc4.xml · derivative · entry 1

Bhatt Elizabeth · CIK 0001748622 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 20,000

Underlying: Common Stock · 20,000 shares

Expires 2032-06-08

F1 · derivative.exercise_date: The option was granted pursuant to the Issuer's Non-Employee Director Compensation Program. The option shall vest in full on the earlier to occur of (A) the first anniversary of the date of grant or (B) the next occurring annual meeting of the Issuer's stockholders, subject to the Reporting Person's continuous service on the board of directors of the Issuer through such vesting date.

SEC source: 0001209191-22-010363 · doc4.xml · derivative · entry 2

Bhatt Elizabeth · CIK 0001748622 · Chief Bus. & Strategy Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 80,500

Underlying: Common Stock · 80,500 shares

Expires 2032-02-15

F2 · derivative.exercise_date: 1/48th of the shares subject to the option shall become vested and exercisable on the Exercisable Date set forth above and 1/48th of the shares subject to the option shall continue to vest each month thereafter, provided that Reporting Person is a service provider to the Issuer as of each such vesting date.

SEC source: 0001209191-22-010363 · doc4.xml · nonDerivative · entry 1

Bhatt Elizabeth · CIK 0001748622 · Chief Bus. & Strategy Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 48,750

F1 · shares: These securities are Restricted Stock Units (RSUs). Each RSU represents a contingent right to receive one shares of the Issuer's Common Stock. 5/48ths of the RSUs shall vest on June 1, 2022 and 1/16th of the RSUs shall vest quarterly thereafter, subject to the Reporting Person continuing as a service provider through each such date.

SEC source: 0001209191-22-002242 · doc4.xml · nonDerivative · entry 1

Bhatt Elizabeth · CIK 0001748622 · Chief Bus. & Strategy Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 31,500

F1 · shares: These securities are Restricted Stock Units (RSUs). Each RSU represents a contingent right to receive one shares of the Issuer's Common Stock. 1/4th of the RSUs shall vest on June 1, 2022 and 1/4th of the RSUs shall vest every six months thereafter, subject to the Reporting Person continuing as a service provider through each such date.

SEC source: 0001209191-21-060075 · doc4.xml · derivative · entry 1

Bhatt Elizabeth · CIK 0001748622 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 40,000

Underlying: Common Stock · 40,000 shares

Expires 2031-10-05

F1 · derivative.exercise_date: The shares subject to the option will vest in substantially equal monthly installments over three years, commencing on August 25, 2021, subject to the Reporting Person's continued service with the Issuer through each vesting date.

SEC source: 0001209191-21-053721 · doc4.xml · derivative · entry 3

Bhatt Elizabeth · CIK 0001748622 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · By LWAC D&O LLC

Disclosed balance after: 0

Underlying: Common Stock · 9,047 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: On August 25, 2021, pursuant to that certain Agreement and Plan of Merger, dated as of May 26, 2021 (the "Merger Agreement"), by and among the Issuer (f/k/a Locust Walk Acquisition Corp.), Locust Walk Merger Sub, Inc. ("Merger Sub"), and eFFECTOR Therapeutics, Inc. ("Old eFFECTOR"), Merger Sub merged with and into Old eFFECTOR with Old eFFECTOR surviving as a wholly owned subsidiary of the Issuer (the "Merger"). In connection with and upon consummation of the Merger, each of the Issuer's outstanding shares of Class B Common Stock automatically converted into one share of Class A Common Stock.

F1 · price: On August 25, 2021, pursuant to that certain Agreement and Plan of Merger, dated as of May 26, 2021 (the "Merger Agreement"), by and among the Issuer (f/k/a Locust Walk Acquisition Corp.), Locust Walk Merger Sub, Inc. ("Merger Sub"), and eFFECTOR Therapeutics, Inc. ("Old eFFECTOR"), Merger Sub merged with and into Old eFFECTOR with Old eFFECTOR surviving as a wholly owned subsidiary of the Issuer (the "Merger"). In connection with and upon consummation of the Merger, each of the Issuer's outstanding shares of Class B Common Stock automatically converted into one share of Class A Common Stock.

F1 · derivative.exercise_date: On August 25, 2021, pursuant to that certain Agreement and Plan of Merger, dated as of May 26, 2021 (the "Merger Agreement"), by and among the Issuer (f/k/a Locust Walk Acquisition Corp.), Locust Walk Merger Sub, Inc. ("Merger Sub"), and eFFECTOR Therapeutics, Inc. ("Old eFFECTOR"), Merger Sub merged with and into Old eFFECTOR with Old eFFECTOR surviving as a wholly owned subsidiary of the Issuer (the "Merger"). In connection with and upon consummation of the Merger, each of the Issuer's outstanding shares of Class B Common Stock automatically converted into one share of Class A Common Stock.

F1 · derivative.expiration_date: On August 25, 2021, pursuant to that certain Agreement and Plan of Merger, dated as of May 26, 2021 (the "Merger Agreement"), by and among the Issuer (f/k/a Locust Walk Acquisition Corp.), Locust Walk Merger Sub, Inc. ("Merger Sub"), and eFFECTOR Therapeutics, Inc. ("Old eFFECTOR"), Merger Sub merged with and into Old eFFECTOR with Old eFFECTOR surviving as a wholly owned subsidiary of the Issuer (the "Merger"). In connection with and upon consummation of the Merger, each of the Issuer's outstanding shares of Class B Common Stock automatically converted into one share of Class A Common Stock.

F2 · ownership.nature: Represents shares held directly by the Sponsor, of which LWAC D&O LLC is a member.

SEC source: 0001209191-21-053721 · doc4.xml · derivative · entry 2

Bhatt Elizabeth · CIK 0001748622 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · By LWAC D&O LLC

Disclosed balance after: 8,453

Underlying: Common Stock · 8,453 shares

Expires not disclosed

F1 · derivative.exercise_price: On August 25, 2021, pursuant to that certain Agreement and Plan of Merger, dated as of May 26, 2021 (the "Merger Agreement"), by and among the Issuer (f/k/a Locust Walk Acquisition Corp.), Locust Walk Merger Sub, Inc. ("Merger Sub"), and eFFECTOR Therapeutics, Inc. ("Old eFFECTOR"), Merger Sub merged with and into Old eFFECTOR with Old eFFECTOR surviving as a wholly owned subsidiary of the Issuer (the "Merger"). In connection with and upon consummation of the Merger, each of the Issuer's outstanding shares of Class B Common Stock automatically converted into one share of Class A Common Stock.

F3 · derivative.exercise_price: Pursuant to an agreement by and between the Issuer and Locust Walk Sponsor, LLC (the "Sponsor"), concurrent with the consummation of the Merger, these shares of Class B Common Stock were forfeited to the Issuer immediately prior to the Merger.

F1 · derivative.exercise_date: On August 25, 2021, pursuant to that certain Agreement and Plan of Merger, dated as of May 26, 2021 (the "Merger Agreement"), by and among the Issuer (f/k/a Locust Walk Acquisition Corp.), Locust Walk Merger Sub, Inc. ("Merger Sub"), and eFFECTOR Therapeutics, Inc. ("Old eFFECTOR"), Merger Sub merged with and into Old eFFECTOR with Old eFFECTOR surviving as a wholly owned subsidiary of the Issuer (the "Merger"). In connection with and upon consummation of the Merger, each of the Issuer's outstanding shares of Class B Common Stock automatically converted into one share of Class A Common Stock.

F3 · derivative.exercise_date: Pursuant to an agreement by and between the Issuer and Locust Walk Sponsor, LLC (the "Sponsor"), concurrent with the consummation of the Merger, these shares of Class B Common Stock were forfeited to the Issuer immediately prior to the Merger.

F1 · derivative.expiration_date: On August 25, 2021, pursuant to that certain Agreement and Plan of Merger, dated as of May 26, 2021 (the "Merger Agreement"), by and among the Issuer (f/k/a Locust Walk Acquisition Corp.), Locust Walk Merger Sub, Inc. ("Merger Sub"), and eFFECTOR Therapeutics, Inc. ("Old eFFECTOR"), Merger Sub merged with and into Old eFFECTOR with Old eFFECTOR surviving as a wholly owned subsidiary of the Issuer (the "Merger"). In connection with and upon consummation of the Merger, each of the Issuer's outstanding shares of Class B Common Stock automatically converted into one share of Class A Common Stock.

F3 · derivative.expiration_date: Pursuant to an agreement by and between the Issuer and Locust Walk Sponsor, LLC (the "Sponsor"), concurrent with the consummation of the Merger, these shares of Class B Common Stock were forfeited to the Issuer immediately prior to the Merger.

F2 · ownership.nature: Represents shares held directly by the Sponsor, of which LWAC D&O LLC is a member.

SEC source: 0001209191-21-053721 · doc4.xml · nonDerivative · entry 1

Bhatt Elizabeth · CIK 0001748622 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · By LWAC D&O LLC

Disclosed balance after: 9,047

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: On August 25, 2021, pursuant to that certain Agreement and Plan of Merger, dated as of May 26, 2021 (the "Merger Agreement"), by and among the Issuer (f/k/a Locust Walk Acquisition Corp.), Locust Walk Merger Sub, Inc. ("Merger Sub"), and eFFECTOR Therapeutics, Inc. ("Old eFFECTOR"), Merger Sub merged with and into Old eFFECTOR with Old eFFECTOR surviving as a wholly owned subsidiary of the Issuer (the "Merger"). In connection with and upon consummation of the Merger, each of the Issuer's outstanding shares of Class B Common Stock automatically converted into one share of Class A Common Stock.

F2 · ownership.nature: Represents shares held directly by the Sponsor, of which LWAC D&O LLC is a member.

SEC source: 0001209191-21-047874 · doc4.xml · derivative · entry 4

Bhatt Elizabeth · CIK 0001748622 · Chief Bus. & Strategy Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 292,632

Underlying: Common Stock · 9,000 shares

Expires 2030-03-06

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_date: 1/4th of the shares subject to the option became vested on the Exercise Date and 1/48th of the shares subject to the option vest monthly thereafter, provided that the reporting person is a service provider to the issuer on each such vest date.

SEC source: 0001209191-21-047874 · doc4.xml · nonDerivative · entry 3

Bhatt Elizabeth · CIK 0001748622 · Chief Bus. & Strategy Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

F2 · price: The price reported in column is a weighted average price. These shares were sold in multiple transactions at prices ranging from $37.27 to $37.61, inclusive. The reporting person undertakes to provide Applied Molecular Transport, Inc., any security holder of Applied Molecular Transport, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

SEC source: 0001209191-21-047874 · doc4.xml · nonDerivative · entry 2

Bhatt Elizabeth · CIK 0001748622 · Chief Bus. & Strategy Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,360

F1 · price: The price reported in column is a weighted average price. These shares were sold in multiple transactions at prices ranging from $36.00 to $36.99, inclusive. The reporting person undertakes to provide Applied Molecular Transport, Inc., any security holder of Applied Molecular Transport, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

SEC source: 0001209191-21-047874 · doc4.xml · nonDerivative · entry 1

Bhatt Elizabeth · CIK 0001748622 · Chief Bus. & Strategy Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 9,000

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001209191-21-027993 · doc4.xml · derivative · entry 5

Bhatt Elizabeth · CIK 0001748622 · Chief Bus. & Strategy Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 301,632

Underlying: Common Stock · 9,000 shares

Expires 2030-03-06

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · derivative.exercise_date: 1/4th of the shares subject to the grant become vested on the Exercisable Date set forth above and 1/48th of the shares subject to the option vest monthly thereafter, provided that the reporting person remains a service provider to the issuer on each such vest date.

SEC source: 0001209191-21-027993 · doc4.xml · nonDerivative · entry 4

Bhatt Elizabeth · CIK 0001748622 · Chief Bus. & Strategy Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

F3 · price: The price reported in column is a weighted average price. These shares were sold in multiple transactions at prices ranging from $41.00 to $41.55, inclusive. The reporting person undertakes to provide Align Technology, Inc., any security holder of Align Technology, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

SEC source: 0001209191-21-027993 · doc4.xml · nonDerivative · entry 3

Bhatt Elizabeth · CIK 0001748622 · Chief Bus. & Strategy Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,612

F2 · price: The price reported in column is a weighted average price. These shares were sold in multiple transactions at prices ranging from $39.95 to $40.94, inclusive. The reporting person undertakes to provide Align Technology, Inc., any security holder of Align Technology, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

SEC source: 0001209191-21-027993 · doc4.xml · nonDerivative · entry 2

Bhatt Elizabeth · CIK 0001748622 · Chief Bus. & Strategy Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 8,029

F1 · price: The price reported in column is a weighted average price. These shares were sold in multiple transactions at prices ranging from $38.86 to $39.80, inclusive. The reporting person undertakes to provide Align Technology, Inc., any security holder of Align Technology, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

SEC source: 0001209191-21-027993 · doc4.xml · nonDerivative · entry 1

Bhatt Elizabeth · CIK 0001748622 · Chief Bus. & Strategy Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 9,000

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001209191-21-017303 · doc4.xml · derivative · entry 1

Bhatt Elizabeth · CIK 0001748622 · Chief Bus. & Strategy Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 63,000

Underlying: Common Stock · 63,000 shares

Expires 2031-03-01

F1 · derivative.exercise_date: 1/48th of the shares subject to the option shall become vested and exercisable on April 1, 2021 and 1/48th of the shares subject to the option shall become vested and exercisable each month thereafter, provided that the reporting person is a service provider to the issuer on each such vest date.

SEC source: 0000899243-21-002110 · doc4.xml · derivative · entry 1

Bhatt Elizabeth · CIK 0001748622 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · By LWAC D&O LLC

Disclosed balance after: 17,500

Underlying: Class A Common Stock · 17,500 shares

Expires not disclosed

F1 · derivative.exercise_price: The shares of Class B common stock will automatically convert into shares of Class A common stock at the time of the issuer's initial business combination on a one-for-one basis, subject to certain adjustments described in the issuer's charter documents and have no expiration date.

F2 · kind: Allocated to the reporting person as a member of LWAC D&O LLC, a member of Locust Walk Sponsor, LLC, for service on the issuer's board of directors.

F3 · shares: The reporting person disclaims beneficial ownership of these securities, except to the extent of her pecuniary interest therein, and this report shall not be deemed an admission that the reporting person is the beneficial owner of such securities for any other purpose.

F2 · price: Allocated to the reporting person as a member of LWAC D&O LLC, a member of Locust Walk Sponsor, LLC, for service on the issuer's board of directors.

F1 · derivative.exercise_date: The shares of Class B common stock will automatically convert into shares of Class A common stock at the time of the issuer's initial business combination on a one-for-one basis, subject to certain adjustments described in the issuer's charter documents and have no expiration date.

F1 · derivative.expiration_date: The shares of Class B common stock will automatically convert into shares of Class A common stock at the time of the issuer's initial business combination on a one-for-one basis, subject to certain adjustments described in the issuer's charter documents and have no expiration date.

SEC source: 0001567619-19-005390 · doc1.xml · nonDerivative · entry 1

Bhatt Elizabeth · CIK 0001748622 · Chief Operating Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 238,155

F1 · kind: The shares were sold solely to satisfy tax or other government withholding obligations in connection with the vesting of Restricted Stock Units ("RSUs") of the Issuer.

F2 · balance_after: Includes 231,625 RSUs.

SEC source: 0001567619-19-001519 · doc1.xml · nonDerivative · entry 1

Bhatt Elizabeth · CIK 0001748622 · Chief Operating Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 239,126

F1 · shares: Grant of Restricted Stock Units ("RSUs"). The reporting person is entitled to one (1) share of Common Stock for each one(1) RSU upon the vesting thereof.

F2 · balance_after: Includes (i) 2,062 shares acquired under the Issuer's Employee Stock Purchase Plan on November 30, 2018 and (ii) 234,000 RSUs.

SEC source: 0001567619-19-001514 · doc1.xml · nonDerivative · entry 1

Bhatt Elizabeth · CIK 0001748622 · Chief Operating Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 80,564

F1 · shares: Grant of Restricted Stock Units ("RSUs"). The reporting person is entitled to one (1) share of Common Stock for each one(1) RSU upon the vesting thereof.

F2 · balance_after: Includes 77,500 RSUs.

SEC source: 0001567619-18-002537 · doc1.xml · derivative · entry 1

Bhatt Elizabeth · CIK 0001748622 · Chief Operating Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 65,000

Underlying: Common Stock · 65,000 shares

Expires 2028-09-11

F1 · derivative.exercise_date: The Shares subject to the option vest in two successive annual installments, with 40% of the Shares subject to the option vesting on September 11, 2019 and 60% of the Shares subject to the option vesting on September 11, 2020, subject to the reporting person's continued employment or service relationship with the Issuer on each such vesting date.